Rezolute, Inc.
Key Metrics
Market Snapshot
About
Rezolute, Inc. is a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases. The company focuses on treatments for congenital hyperinsulinism, severe hypoglycemia, and diabetes using novel formulations and delivery mechanisms. Rezolute leverages proprietary technology platforms to address unmet needs in rare and orphan endocrine disorders.